SRGAQ — Surgalign Holdings Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual cashflow statement for Surgalign Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	C2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-3.12	-212	-33.8	-127	-54.6
Depreciation
Deferred Taxes
Non-Cash Items	20	178	-51	89.7	7.11
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-9.54	-15.8	-8.01	-17.3	-5.55
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Cash from Operating Activities	17.3	-9.46	-88	-51.8	-52.1
Capital Expenditures	-14.7	-16.4	-14	-14.1	-7.26
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-18	-99.7	405	-10.8	0
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Other Investing Cash Flow
Cash from Investing Activities	-32.7	-116	391	-24.8	-7.26
Financing Cash Flow Items	-1.04	-0.826	-1.74	0.407	-3.83
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	4.09	120	-263	82.6	24.7
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-11.4	-5.34	38.4	7.33	-35